Public Employees Retirement Association of Colorado held its stake in shares of Exactech, Inc. (NASDAQ:EXAC) during the first quarter, according to its most recent 13F filing with the SEC. The firm owned 9,627 shares of the medical equipment provider’s stock at the end of the first quarter. Public Employees Retirement Association of Colorado owned 0.07% of Exactech worth $243,000 as of its most recent filing with the SEC.

Other hedge funds have also made changes to their positions in the company. Wedge Capital Management L L P NC increased its stake in shares of Exactech by 22.1% in the first quarter. Wedge Capital Management L L P NC now owns 51,300 shares of the medical equipment provider’s stock valued at $1,293,000 after buying an additional 9,300 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of Exactech by 13.0% in the first quarter. Wells Fargo & Company MN now owns 57,447 shares of the medical equipment provider’s stock valued at $1,448,000 after buying an additional 6,590 shares in the last quarter. Kirr Marbach & Co. LLC IN increased its stake in shares of Exactech by 1.2% in the first quarter. Kirr Marbach & Co. LLC IN now owns 10,760 shares of the medical equipment provider’s stock valued at $271,000 after buying an additional 125 shares in the last quarter. Thomson Horstmann & Bryant Inc. acquired a new stake in shares of Exactech during the first quarter valued at $4,857,000. Finally, Rice Hall James & Associates LLC increased its stake in shares of Exactech by 74.1% in the first quarter. Rice Hall James & Associates LLC now owns 99,270 shares of the medical equipment provider’s stock valued at $2,502,000 after buying an additional 42,256 shares in the last quarter. Institutional investors own 57.30% of the company’s stock.

Institutional Ownership by Quarter for Exactech (NASDAQ:EXAC)

Exactech, Inc. (EXAC) opened at 30.65 on Friday. Exactech, Inc. has a 12 month low of $22.20 and a 12 month high of $31.90. The stock’s 50 day moving average is $30.49 and its 200 day moving average is $27.30. The company has a market cap of $438.66 million, a PE ratio of 1277.08 and a beta of 1.01.

Exactech (NASDAQ:EXAC) last released its quarterly earnings results on Tuesday, April 25th. The medical equipment provider reported $0.34 EPS for the quarter, beating the Zacks’ consensus estimate of $0.31 by $0.03. The firm had revenue of $69.48 million for the quarter, compared to analyst estimates of $67.05 million. Exactech had a net margin of 0.13% and a return on equity of 7.27%. The company’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.31 earnings per share. Equities analysts predict that Exactech, Inc. will post $1.30 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Public Employees Retirement Association of Colorado Has $243,000 Position in Exactech, Inc. (EXAC)” was posted by Financial Market News and is the property of of Financial Market News. If you are accessing this news story on another domain, it was copied illegally and republished in violation of U.S. and international copyright & trademark legislation. The correct version of this news story can be accessed at https://www.financial-market-news.com/2017/06/17/public-employees-retirement-association-of-colorado-has-243000-position-in-exactech-inc-exac.html.

Several brokerages have recently weighed in on EXAC. Zacks Investment Research upgraded Exactech from a “sell” rating to a “hold” rating in a research note on Monday, May 1st. TheStreet upgraded Exactech from a “c+” rating to a “b” rating in a research note on Tuesday, April 25th.

In other Exactech news, CFO Joel C. Phillips sold 7,610 shares of the business’s stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $30.71, for a total value of $233,703.10. Following the transaction, the chief financial officer now directly owns 99,907 shares in the company, valued at $3,068,143.97. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director William B. Locander sold 988 shares of the business’s stock in a transaction dated Wednesday, May 31st. The shares were sold at an average price of $30.34, for a total transaction of $29,975.92. Following the completion of the transaction, the director now owns 8,555 shares in the company, valued at $259,558.70. The disclosure for this sale can be found here. 28.30% of the stock is owned by insiders.

Exactech Company Profile

Exactech, Inc develops, manufactures, markets, distributes and sells orthopedic implant devices, related surgical instrumentation and biologic services to hospitals and physicians. The Company’s segments include knee, hip, biologics and spine, extremity and other products. Its other products segment includes miscellaneous sales categories, such as bone cement, instrument rental fees, shipping charges and other product lines.

Want to see what other hedge funds are holding EXAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exactech, Inc. (NASDAQ:EXAC).

Receive News & Ratings for Exactech Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc. and related companies with MarketBeat.com's FREE daily email newsletter.